clinical trial · NCT07495852
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
GlaucomaGen 2 Travoprost Intracameral ImplantTimolol eye drops 0.5%Sham Procedureplacebo eye drops
brief summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
started
Feb 17, 2026
primary completion
Jun 1, 2028
completion
Mar 1, 2032
last updated
Mar 30, 2026
detailed description
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant Compared to Timolol Ophthalmic Solution 0.5% Administered Twice Daily in Subjects with Open-Angle Glaucoma or Ocular Hypertension
official title
Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol